This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXNPEI3A0L7_L.jpg
Gomez, who has been serving as the finance chief of Dentsply since August 2019, will succeed David Meline, who has decided to retire, Moderna said. (https://
Before joining Dentsply, Gomez was with drug distributor Cardinal Health Inc (NYSE:CAH) for over a decade in several roles, including CFO.
Moderna’s current finance chief Meline joined the company in June 2020, as it was preparing to advance its COVID-19 vaccine into late-stage development.
The company’s mRNA-based vaccine, branded Spikevax, along with a rival shot from Pfizer (NYSE:PFE), has been at the forefront of global vaccination efforts and is cleared for use in over 70 countries, including the United States.
Meline will remain with Moderna as a consultant as Gomez transitions to the role of CFO, according to the company.
Gomez will get an initial annual base salary of $700,000, Moderna said in a filing.
